Quest Common Stock Total Equity from 2010 to 2024

DGX Stock  USD 163.59  0.30  0.18%   
Quest Diagnostics Common Stock Total Equity yearly trend continues to be fairly stable with very little volatility. Common Stock Total Equity will likely drop to about 1.9 M in 2024. Common Stock Total Equity is the total value of common stock equity held by shareholders, representing their ownership interest in the company. View All Fundamentals
 
Common Stock Total Equity  
First Reported
1996-12-31
Previous Quarter
M
Current Value
M
Quarterly Volatility
166.2 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Quest Diagnostics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Quest Diagnostics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 265.1 M, Interest Expense of 99.3 M or Selling General Administrative of 1.5 B, as well as many indicators such as Price To Sales Ratio of 1.13, Dividend Yield of 0.0214 or PTB Ratio of 3.0. Quest financial statements analysis is a perfect complement when working with Quest Diagnostics Valuation or Volatility modules.
  
Check out the analysis of Quest Diagnostics Correlation against competitors.

Latest Quest Diagnostics' Common Stock Total Equity Growth Pattern

Below is the plot of the Common Stock Total Equity of Quest Diagnostics Incorporated over the last few years. It is the total value of common stock equity held by shareholders, representing their ownership interest in the company. Quest Diagnostics' Common Stock Total Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Quest Diagnostics' overall financial position and show how it may be relating to other accounts over time.
Common Stock Total Equity10 Years Trend
Slightly volatile
   Common Stock Total Equity   
       Timeline  

Quest Common Stock Total Equity Regression Statistics

Arithmetic Mean1,916,595
Geometric Mean1,782,685
Coefficient Of Variation24.07
Mean Deviation224,168
Median2,000,000
Standard Deviation461,305
Sample Variance212.8B
Range2M
R-Value0.39
Mean Square Error194.7B
R-Squared0.15
Significance0.15
Slope40,002
Total Sum of Squares3T

Quest Common Stock Total Equity History

20241.9 M
20232.3 M
2013M
20122.2 M
20112.1 M
2010288 K

About Quest Diagnostics Financial Statements

Quest Diagnostics investors use historical fundamental indicators, such as Quest Diagnostics' Common Stock Total Equity, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Quest Diagnostics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Common Stock Total Equity2.3 M1.9 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Quest Stock Analysis

When running Quest Diagnostics' price analysis, check to measure Quest Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Quest Diagnostics is operating at the current time. Most of Quest Diagnostics' value examination focuses on studying past and present price action to predict the probability of Quest Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Quest Diagnostics' price. Additionally, you may evaluate how the addition of Quest Diagnostics to your portfolios can decrease your overall portfolio volatility.